Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
3.030
+0.040 (1.34%)
At close: Aug 13, 2025, 4:00 PM
4.280
+1.250 (41.25%)
Pre-market: Aug 14, 2025, 9:22 AM EDT
Biomerica Market Cap
Biomerica has a market cap or net worth of $7.71 million as of August 14, 2025. Its market cap has increased by 37.74% in one year.
Market Cap
7.71M
Enterprise Value
5.20M
1-Year Change
37.74%
Ranking
Category
Stock Price
$3.03
Market Cap Chart
Since August 29, 2016, Biomerica's market cap has decreased from $24.30M to $7.71M, a decrease of -68.26%. That is a compound annual growth rate of -12.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 7.70M | 54.00% |
| Dec 31, 2024 | 5.00M | -76.19% |
| Dec 29, 2023 | 21.00M | -53.33% |
| Dec 30, 2022 | 45.00M | -7.60% |
| Dec 31, 2021 | 48.70M | -16.75% |
| Dec 31, 2020 | 58.50M | 96.97% |
| Dec 31, 2019 | 29.70M | 92.86% |
| Dec 31, 2018 | 15.40M | -51.72% |
| Dec 29, 2017 | 31.90M | 69.68% |
| Dec 30, 2016 | 18.80M | -22.63% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 583.99B |
| Johnson & Johnson | 417.29B |
| AbbVie | 348.35B |
| UnitedHealth Group | 230.66B |
| AstraZeneca | 227.85B |
| Abbott Laboratories | 227.60B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |